Clinical Trial: Comparison of efficacy and safety of one and three doses of benzathine penicillin in the treatment of early syphilis: a multicenter, prospective, open-label, non-inferiority randomized controlled trial (China)

Posted On: 2026-09-08

China, Sept. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Comparison of efficacy and safety of one and three doses of benzathine penicillin in the treatment of early syphilis: a multicenter, prospective, open-label, non-inferiority randomized controlled trial'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600131878

Registration Time: 2026/09/07

Type: Interventional study

Primary Sponsor: Institute of Dermatology and Hospital for Skin Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=336526

Published by HT Digital Content Services with p...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Comparison of efficacy and safety of one and three doses of benzathine penicillin in the treatment of early syphilis: a multicenter, prospective, open-label, non-inferiority randomized controlled trial (China)